Readhub | 热门话题

my country’s first deep-sea floating wind power station completed the main project construction in Qingdao

Visit the original URL On the 2nd, it was learned from CNOOC that my country’s first deep-sea floating wind power platform – “CNOOC Guanlan” completed the main project construction in Qingdao. This marks an important progress in the construction of the world’s first “Double Hundred” offshore wind power project with a water depth of over […]

my country’s first deep-sea floating wind power station completed the main project construction in Qingdao Read More »

It is reported that Sony will release the FE 20-70mm F4 G lens this month, priced at $1600

Visit the original URL The new cool products are free to try for the first time, and there are many high-quality experts sharing unique life experiences. Come to Sina Crowdtest and experience the most cutting-edge, most interesting and fun products in various fields~! Download the client and get exclusive benefits! According to news from IT

It is reported that Sony will release the FE 20-70mm F4 G lens this month, priced at $1600 Read More »

US chip equipment giant will invest in Korean glass substrate manufacturers

Visit the original URL Applied Materials (AMAT), the largest chip equipment manufacturer in the United States, will participate in the capital increase project of Absolics, a chip glass substrate manufacturer owned by South Korean chemical materials company SKC. According to news from the Korean Financial Supervisory Service on the 2nd, SKC recently announced that Absolics

US chip equipment giant will invest in Korean glass substrate manufacturers Read More »

“Huamu Medical” completed the C round of financing of tens of millions of yuan, and Shenzhen Gaoxin Investment Capability led the investment

Visit the original URL Recently, Huamu Medical, a biodegradable medical material and regenerative medicine company, completed tens of millions of yuan in Series C financing. This round of financing was led by Shenzhen High-tech Investment Capital, followed by Shanlan Capital, and Haoyue Capital acted as the exclusive financial advisor for this round of financing. This

“Huamu Medical” completed the C round of financing of tens of millions of yuan, and Shenzhen Gaoxin Investment Capability led the investment Read More »

Gome retail debt-to-equity swap, Huang Guangyu’s shareholding will drop to 19.33%

Visit the original URL Gome Retail (00495.HK) announced the debt-to-equity swap plan on the evening of January 2, 2023. The creditor, Media Asia International Capital Co., Ltd. (hereinafter referred to as the creditor), which owes about HK$416 million in advertising fees, intends to subscribe for Gome with the debt amount. Retail additionally issued shares at

Gome retail debt-to-equity swap, Huang Guangyu’s shareholding will drop to 19.33% Read More »

South Korea’s game industry sales in 2021 will increase by 11.2% year-on-year, hitting a new high

Visit the original URL Yonhap News Agency reported on January 2 that according to the “2022 Korean Game White Paper” released by the Korean Cultural and Creative Content Promotion Institute on the 2nd, the sales of the domestic game market in 2021 will increase by 11.2% year-on-year to 20.9913 trillion won (about 114.6 billion yuan).

South Korea’s game industry sales in 2021 will increase by 11.2% year-on-year, hitting a new high Read More »

Sinopharm: Join hands with Merck to promote the launch and supply of the anti-new coronavirus oral drug Ridrovir (Monoravir Capsules) in mainland China

Visit the original URL Sinopharm Holdings announced on January 2 that the company’s controlling shareholder, China National Pharmaceutical Group Co., Ltd., has signed a cooperation framework agreement with Merck in September 2022, and has been granted the anti-new coronavirus oral drug monogravir jointly developed by Merck and Ridgeback Biotechnology Distribution rights and exclusive import rights

Sinopharm: Join hands with Merck to promote the launch and supply of the anti-new coronavirus oral drug Ridrovir (Monoravir Capsules) in mainland China Read More »

Frontier Bio: The phase II/III clinical trial of FB2001 for injection in patients with new coronavirus infection has been approved

Visit the original URL Frontier Bio announced on January 2 that at present, the company is actively accelerating the Phase II/III clinical trial of FB2001 for injection to treat hospitalized patients with new coronavirus infection and the Phase II clinical trial of FB2001 for aerosol inhalation to treat patients with mild and common coronavirus infection.

Frontier Bio: The phase II/III clinical trial of FB2001 for injection in patients with new coronavirus infection has been approved Read More »

In 2023, Weilai’s third-generation power station and 500kW ultra-fast charging will begin to be deployed

Visit the original URL Pinwan News, January 2, according to Weilai’s official news, in 2023, the third-generation power station and 500kW ultra-fast charging will begin to be deployed. In China, it is planned to build more than 1,700 power stations and more than 20,000 charging piles. Source: NIO In 2022, NIO will build 538 new

In 2023, Weilai’s third-generation power station and 500kW ultra-fast charging will begin to be deployed Read More »